Risk factors for hepatocellular carcinoma
D. Alan Herbst, K. Rajender Reddy – 23 January 2013 – Watch a video presentation of this article
Novel local therapies in hepatocellular carcinoma
Eleni Liapi, Jean‐Francois H. Geschwind – 23 January 2013 – Watch a video presentation of this article
Histopathologic features of hepatocellular carcinoma
Elizabeth M. Brunt – 23 January 2013 – Watch a video presentation of this article
New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next‐generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma
Roongruedee Chaiteerakij, Lewis R. Roberts – 23 January 2013 – Watch a video presentation of this article
Radiological diagnosis of hepatocellular carcinoma
Mark W. Russo, Christoph Wald – 23 January 2013 – Watch a video presentation of this article
Molecular epidemiology of hepatocellular carcinoma
Yujin Hoshida – 23 January 2013 – Watch a video presentation of this article
Novel local therapies in hepatocellular carcinoma
Eleni Liapi, Jean‐Francois H. Geschwind – 23 January 2013 – Watch a video presentation of this article
Radiological diagnosis of hepatocellular carcinoma
Mark W. Russo, Christoph Wald – 23 January 2013 – Watch a video presentation of this article
Spleen stiffness: Toward a noninvasive portal sphygmomanometer?
Juan G. Abraldes, Enric Reverter, Annalisa Berzigotti – 21 January 2013
Hepatocyte caspase‐8 is an essential modulator of steatohepatitis in rodents
Maximilian Hatting, Gang Zhao, Fabienne Schumacher, Gernot Sellge, Malika Al Masaoudi, Nikolaus Gaβler, Mark Boekschoten, Michael Müller, Christian Liedtke, Francisco Javier Cubero, Christian Trautwein – 21 January 2013 – In human and murine models of nonalcoholic steatohepatitis (NASH), increased hepatocyte apoptosis is a critical mechanism contributing to inflammation and fibrogenesis. Caspase 8 (Casp8) is essential for death‐receptor‐mediated apoptosis activity and therefore its modulation might be critical for the pathogenesis of NASH.